Arbuckle Stuart A sold VRTX
February 20, 2024 · Form 4 insider transaction
Arbuckle Stuart A sold 4,804 shares of Vertex Pharmaceuticals Incorporated at $420.79 per share, a transaction worth $2.02M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
4,804
Price
$420.79
Total value
$2.02M
InsiderArbuckle Stuart A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 20, 2024
Filing dateFebruary 21, 2024
Shares owned after63,042
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.